Liquid Biopsy Based Bladder Cancer Diagnostic by Machine Learning
Ērika Bitiņa-Barlote,
No information about this author
Dmitrijs Bļizņuks,
No information about this author
S. Silina
No information about this author
et al.
Diagnostics,
Journal Year:
2025,
Volume and Issue:
15(4), P. 492 - 492
Published: Feb. 18, 2025
Background/Objectives:
The
timely
diagnostics
of
bladder
cancer
is
still
a
challenge
in
clinical
settings.
reliability
conventional
testing
methods
does
not
reach
desirable
accuracy
and
sensitivity,
it
has
an
invasive
nature.
present
study
examines
the
application
machine
learning
to
improve
by
integrating
miRNA
expression
levels,
demographic
routine
laboratory
test
results,
data.
We
proposed
that
merging
these
datasets
would
enhance
diagnostic
accuracy.
Methods:
This
combined
molecular
biology
for
liquid
biopsy,
data,
approach
acquired
data
analysis.
evaluated
urinary
exosome
combination
with
patient
as
well
using
three
models:
Random
Forest,
SVM,
XGBoost
classifiers.
Results:
Based
solely
on
SVM
model
achieved
ROC
curve
area
0.75.
Patient
analysis'
obtained
0.80.
Combining
both
types
enhanced
performance,
resulting
F1
score
0.79
0.85.
feature
importance
analysis
identified
key
predictors,
including
erythrocytes
urine,
age,
several
miRNAs.
Conclusions:
Our
findings
indicate
potential
multi-modal
diagnosis
non-invasive
manner.
Language: Английский
A serum three-microRNA panel: promising biomarkers for renal cell carcinoma screening
Zhenjian Ge,
No information about this author
Shengjie Lin,
No information about this author
Xinji Li
No information about this author
et al.
Journal of Cancer Metastasis and Treatment,
Journal Year:
2025,
Volume and Issue:
unknown
Published: April 27, 2025
Aim:
Renal
cell
carcinoma
(RCC)
screening
is
helpful
to
improve
the
prognosis
of
patients.
However,
existing
RCC
detection
methods
are
not
suitable
for
large-scale
screening.
Serum
microRNAs
(miRNAs)
expected
be
a
convenient,
economical,
and
non-invasive
tool
RCC.
This
study
aimed
identify
relevant
serum
miRNAs
as
diagnostic
markers
Methods:
research
included
112
patients
with
healthy
control
individuals,
carried
out
in
three
distinct
phases.
The
objective
was
diagnosis
using
quantitative
reverse
transcription
polymerase
chain
reaction
(RT-qPCR).
Additionally,
bioinformatics
analyses
were
performed
predict
target
genes
provide
functional
annotations.
Results:
Compared
controls,
highly
expressed
miR-221-3p
lowly
miR-124-3p,
let-7b-5p,
miR-30a-5p,
miR-302d-3p.
After
multiple
rounds
combination
screening,
miR-221-3p,
let-7b-5p
showed
good
predictability.
panel
exhibited
0.838
area
under
curve
(AUC),
achieving
75.00%
sensitivity
77.68%
specificity.
Conclusion:
Our
analysis
demonstrates
that
combining
forms
non-invasive,
remarkably
effective
indicator
renal
carcinoma.
Language: Английский